Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Global Cord Blood Corporation Announces Receipt of Blue Ocean Petition 2022-05-11 04:16
Bora Pharmaceuticals acquires Eden Biologics CDMO Assets 2022-05-10 17:53
OMRON Healthcare Unveils Long-term Corporate Vision, "Going for ZERO, Preventive Care for Health of Society" 2022-05-10 13:00
Robert Wessman-led Aztiq completes $500 million transaction in an alliance with Innobic to create an international pharma powerhouse 2022-05-10 11:00
Brii Bio Announces Positive Data Demonstrating its Long-Acting COVID-19 Neutralizing Antibody Therapy, Amubarvimab/Romlusevimab Combination, Retains Neutralizing Activity Against Omicron BA.2 Subvariant 2022-05-09 19:46
Series A financing round lays foundation for international growth of digital cancer therapeutics Mika 2022-05-09 19:35
SCG Cell Therapy announces clinical trial approval of TCR-T cell therapy for liver cancer in Singapore 2022-05-09 10:28
Takeda Malaysia receives coveted HR accolades by creating an exceptional people experience 2022-05-09 09:05
Takeda Singapore receives coveted HR accolades by creating an exceptional people experience 2022-05-09 09:00
ExoCoBio Receives Japanese Patent for Alleviating Dermatitis with Adipose Stem Cell-Derived Exosome 2022-05-09 07:00
Brii Bio Reports Progress on ESG Commitments in Its Inaugural ESG Report 2022-05-07 09:00
Antengene to Participate in Three Upcoming Investor Conferences in May/June 2022-05-06 08:30
World Lupus Federation Global Survey of People Living with Lupus finds 87% Report at Least One Major Organ Affected by the Disease 2022-05-06 07:00
Insilico Medicine expands synthetic lethality portfolio with the nomination of a preclinical candidate targeting MAT2A for the treatment of MTAP-deleted cancers 2022-05-06 05:00
Insilico Medicine expands synthetic lethality portfolio with nomination of a preclinical candidate targeting MAT2A for the treatment of MTAP-deleted cancers 2022-05-05 23:00
HOYA Vision Care Releases Results of First of its Kind Six-Year MiYOSMART Spectacle Lens Follow-up Clinical Study 2022-05-05 22:12
TIKOMED and IQVIA announce a strategic collaboration for the development of TIKOMED's lead drug platform candidate ILB® 2022-05-05 20:40
SOPHiA GENETICS Announces Nomination of Jean-Michel Cosséry to Board of Directors 2022-05-05 20:27
Leading HealthTech AI company NuraLogix announces new partnership with LaFiya TeleHealth 2022-05-05 20:15
Clinical Trial Approval For ReCOV In The PRC And The Overseas Clinical Trial Progress Of ReCOV 2022-05-05 11:55
1 162 163 164 165 166 502